Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox.
Strauss
Martin H
MH
Division of Cardiology, North York General Hospital, Toronto, Canada. dr.marty@bellnet.ca
Hall
Alistair S
AS
D000804:Angiotensin II / Q000502:physiology; D057911:Angiotensin Receptor Antagonists; D006801:Humans; D009203:Myocardial Infarction / Q000453:epidemiology*; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology*; D011945:Receptors, Angiotensin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D057911:Angiotensin Receptor Antagonists; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D014409:Tumor Necrosis Factor-alpha; D000804:Angiotensin II